welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
Minimal Access Laparoscopic Surgery for Treatment of Ulcerative Colitis and Familial Adenomatous Polyposis Coli in C...BACKGROUND : Laparoscopic restorative pr...
Live Chat About the FAP 310 Clinical Trialhttps://www.youtube.com/watch?v=tKHUFgyO...
Surgical Treatment in Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
Proctocolectomy for Ulcerative Colitis or Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=zlxBwxKX...
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposisIn a randomized clinical chemoprevention...
Pouch-Anal Anastomosis vs Straight Ileoanal Anastomosis in Pediatric Patients: A Meta-AnalysisBACKGROUND : Restorative proctocolectomy...
Jejunal Cancer in Patients with Familial Adenomatous PolyposisWe read with interest the article by Ruy...